T3 Companies
STIM icon

T3 Companies’s Neuronetics STIM Stock Holding History

T3 Companies’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$88K Buy
+37,600
New +$92.3K 0.09% 120

Other funds holding STIM

Physician Wealth Advisors
Physician Wealth Advisors Midvale, Utah $869M AUM 17.6% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

T3 Companies's STIM Position: Q3 2026 in Review

T3 Companies opened a new position in Neuronetics (STIM) in Q3 2026: 37,600 shares worth $88K. The stake represents 0.09% of the portfolio and ranks #120 among its holdings.

6 funds tracked by Wall St. Rank hold STIM as of Q3 2026.

  • T3 Companies held 37,600 shares of Neuronetics worth $88K as of Q3 2026.
  • Neuronetics was a new T3 Companies position in Q3 2026.
  • Neuronetics made up 0.09% of T3 Companies's portfolio in Q3 2026, its #120 holding.
  • 6 funds tracked by Wall St. Rank held Neuronetics as of Q3 2026.

Based on T3 Companies's 13F filing for Q3 2026, filed 22 Oct 2026.